Embed Size (px)
Citation preview
ヒルトン成⽥
H I L T O N N A R I T A千葉県成⽥市⼩菅4 5 6 2 8 6 - 0 1 2 7456 Kosuge Narita CHIBA 286-0127 JAPAN
NVND-2018International Conference on
NeurovascularandNeurodegenerativeDiseases
October 15-172018
Venue Floor Plan
Day-1Program
07:30 Registrations and Introduction to NVND-2018 @ Foyer Area
Keynote Session @ Royal Hall 3
08:30 New Approaches in Neurological Diseases: From the Digital to the Electronic Ogan Gurel, Daegu Gyeongbuk Institute of Science & Technology, South Korea
09:10 The Green Tea Amino Acid Theanine Accelerates Neurogenesis from Neural Progenitors
Yukio Yoneda, Kanazawa University, Japan
09:50 Mitochondrial Dysfunction in the Mechanism of Neurodegeneration of Familial Form of Parkinson’s Disease
Andrey Y Abramov, UCL Institute of Neurology, UK
10:30 Coffee Break @ Foyer Area
Session 1 @ Royal Hall 3
Diagnostics of Neurodegenerative Diseases: Neuroimaging, Biomarkers and Laboratory Studies
Neurodegenerative Diseases: Prevention, Treatment and Therapeutic Options
Chairs: Yukio Yoneda, Kanazawa University, Japan | Michael J Brenner, University of Michigan, USA
10:45 What if Parkinson’s Disease Symptoms are Cortical? Gordon W Arbuthnott, OIST Graduate University, Japan Marianela Garcia Munoz, OIST Graduate University, Japan
11:05 Incidence, Risk Factors and Genetic Associations of Leukoaraiosis Indicate Pathophysiological Mechanisms in White Matter Lesions Etiology
Chi-Meng Tzeng, Jiansu Institute of Translational Medicine and Translation Medicine Research Center Xiamen University, China
11:25 Endothelial TIGAR Protects Tight Junction Integrity and the Blood Brain Barrier From Excessive Autophagy During Hypoglycemic Stress
Feng Han, Nanjing Medical University, China
11:45 Progressive Neuropathy – Does the Bladder Matter in Multiple Sclerosis (MS)? Gurpreet Singh, NHS, UK
12:05 Role of Green Tea Catechin Metabolites on the Brain: A Study of the Blood-Brain Barrier Permeability and the Neuritogenic Activity
Keiko Unno, University of Shizuoka, Japan
12:25 Terahertz Spectroscopic Diagnosis of Myelin Deficit Brain with Chemometrics Yi Zou, Institute of Fluid Physics, China
12:45 Neurovascular Coupling in the Striatum under Normal and Diseased Condition Yen-Yu Ian Shih, University of North Carolina, USA
13:05 Lunch @ Crown Room
MONDAY, OCTOBER 15, 2018
NVND-2018 MEETING GUIDE 3
14:00 Terahertz Imaging and Electromagnetic Model of Axon Demyelination in Alzheimer’s Disease
Ogan Gurel, Daegu Gyeongbuk Institute of Science & Technology, South Korea
14:20 Parkinson’s Disease in Japan Yuko Harada, Yamato Tokushukai Hospital, Japan
14:40 Neurovascular Manifestations of Oxidative Stress in Diabetes, Smoking, and Surgical Wound Healing
Michael J Brenner, University of Michigan, USA
15:00 Can Valproic Acid Treat Neurodegenerative Diseases? Atsuko Kimura, Tokyo Metropolitan Institute of Medical Science, Japan
15:20 Autoimmune Biomarkers and AI Algorithms Could Lead to New Diagnosis and Treatment Options in Neurodegenerative Diseases Such as Glaucoma
Franz Grus, University Medical Center, Germany
15:40 Networking Break @ Foyer Area
Session 2 @ Royal Hall 3 Advances in Stroke Management | Stroke: Prevention, Treatment and Recovery
Chair: Alberto Friedmann, Indiana State University, USA
15:55 Stroke Cerebroprotection: Role of Endogenous Progesterone and its Intaracellular Receptors Rachida Guennoun, INSERM, University Paris-Sud and University Paris-Saclay, France
16:15 A Nearly Full-recovery From AVM Hemorrhagic Stroke 17 Years After Insult Using a New Integrated Neurodevelopmental Approach. A Case Study
Alberto Friedmann, Indiana State University, USA
16:35 Dual-afferent Sensory Input Training for Voluntary Movement After Stroke: A Pilot Randomized Controlled Study
Seahyun Bae, Dongshin University, South Korea
16:55 Longitudinal Measurement of Blood-brain Barrier Permeability and Cerebrospinal Fluid Level of Matrix Metalloproteinases in Rhesus Monkeys Subjected to Transient Ischemic Stroke
Zhihui Zhong, Sichuan University, China
17:15 Patients with the History of Stroke: Drug Treatment and Outcomes in Real Outpatient Practice
Mikhail Loukianov, National Medical Center for Preventive Medicine, Russia
17:35 Neural Activity-dependent Transcription Factor Npas4 Plays a Crucial Role in Neuronal Survival After Ischemic Stroke
Akio Tsuboi, Osaka University, Japan
Day-1Program MONDAY, OCTOBER 15, 2018
4 NVND-2018 MEETING GUIDE
Keynote Session @ Royal Hall 3
08:00 Neuropathology and Diagnosis of Dementia: Novel Approach Rajendra Badgaiyan, Icahn School of Medicine at Mt. Sinai, USA
08:40 Structural and Functional MRI Correlates of Poststroke Depression Wai Kwong Tang, Chinese University of Hong Kong, China & CUHK Shenzhen Research
Institute, China
Symposium on: “Novel Therapeutic Targets for Neurodegeneration”
Chair: Katsura Takano, Osaka Prefecture University, Japan
09:20 The Role of Prostaglandin E2 in Dopaminergic Neurodegeneration of Parkinson’s Disease
Yuri Ikeda-Matsuo, Hokuriku University, Japan
09:40 Transglutaminases in Neurodegenerative Diseases Katsura Takano, Osaka Prefecture University, Japan
10:00 Protective Role of NDRG2 in Blood-brain Barrier Integrity Following Ischemia Mika Takarada-Iemata, Kanazawa University, Japan
10:20 Challenge to Elucidate the Cause of Depression-like Symptoms by Individuality Hirotaka Oikawa, Suzuka University of Medical Science, Japan
10:40 Coffee Break @ Foyer Area
Session 3 @ Royal Hall 3 Alzheimer’s Disease, Dementia and Mild Cognitive Impairment Translational Insights and Therapeutic Opportunities
Chair: Rajendra Badgaiyan, Icahn School of Medicine at Mt. Sinai, USA
10:55 Is Isorhynchophylline a Promising Agent for Alzheimer’s Disease: Pharmaco-logical Studies on TgCRND8 Transgenic Mice
Zhi-Xiu Lin, The Chinese University of Hong Kong, Hong Kong
11:15 Magnolol, Honokiol and their Combination Ameliorate the Cognitive Deficits Induced by Beta Amyloid1-42 in Rats via GSK-3β Signaling Pathway
Yan-Fang Xian, The Chinese University of Hong Kong, Hong Kong
11:35 Neuronal Signaling Imbalances Underlie Early Sensory Deficit in Dementia Lavinia Alberi, Swiss Integrative Center for Human Health, Switzerland
11:55 Cholinergic Grb2-Associated-Binding Protein 1 Regulates Cognitive Function through SK Channel
Ying-Mei Lu, Zhejiang University, China
TUESDAY, OCTOBER 16, 2018Day-2Program
NVND-2018 MEETING GUIDE 5
12:15 Disease Management in Alzheimer’s Disease Centre: The Analysis of Dementia Cases Followed Up from Diagnosis to Death
Nataliya Mikhaylova, IFSBSI “Mental Health Research Center”, Russia
12:35 Automated Operand Conditioning as a Reproducible Cognitive Challenge to Study Treatment Effects in Pig Models
Christian Manteuffel, Leibniz Institute for Farm Animal Biology, Germany
12:55 Therapeutic Potential of Targeting NLRP3 Inflammasome for Alzheimer’s Disease Dong Sun, Virginia Commonwealth University, USA
13:15 Lunch @ Crown Room
14:05 Activated Forms of Astrocytes with Higher GLT-1 Expression are Associated with Cognitive Normal Subjects with Alzheimer Pathology in Human Brain
Eiji Kobayashi, Sapporo Medical University, Japan
14:25 Should the Treatment of Amyloidosis be Personified? Molecular Mechanism of Amyloid Formation by Abeta Peptide and its Fragments
Oxana V Galzitskaya, Institute of Protein Research, Russia
14:45 Determination of Regions Involved in Amyloid Fibril Formation: Abeta Peptide and its Fragments
Alexey Surin, Institute of Protein Research, Russia
15:05 Predictive Factors for Dementia and Cognitive Impairment Among Residents Living in the Veterans’ Retirement Communities in Taiwan: Implications for Cognitive Health Promotion Activities
Liang-Yu Chen, Taipei Veterans General Hospital, Taiwan
15:25 Molecular Hydrogen Inhalation Treatment for Neurovascular and Neuro-degenerative Disease
Hirohisa Ono, Juntendo University, Japan
15:45 Sphingosine 1-Phosphate Metabolism in Alzheimer’s Disease Olivier Cuvillier, INSERM, France
16:05 Multisession Cyberknife Radiosurgery for Large AVM and AVM in Eloquent Regions Shinichiro Miyazaki, Shin-yurigaoka General Hospital, Japan
16:25 Integration of Gene Expression and GWAS Results Supports Involvement of Calcium Signaling in Schizophrenia
Libi Hertzberg, Shalvata Mental Health Center, Israel
16:45 Coffee Break @ Foyer Area
17:00 Poster Presentations @ Foyer Area
Day-2Program TUESDAY, OCTOBER 16, 2018
6 NVND-2018 MEETING GUIDE
NVND-01 Social Participation Related to Cognitive Performance in Community-dwelling Older Adults: A Prospective Cohort Study in Japan
Kimiko Tomioka, Nara Prefectural Health Research Center, Japan
NVND-02 Analysis of Micro and Macrolinguistic Aspects in the Narratives of Individuals with Alzheimer’s Disease, Mild Cognitive Impairment and No Cognitive Impairment
Cintia Toledo, University of São Paulo, Brazil
NVND-03 Effect of Erinacine A-enriched Hericium erinaceus on Anti-aging in Senescence Accelerated Mice
Liya Lee, Grape King Bio Ltd., Taiwan
NVND-04 Effect of Erinacine A-enriched Hericium erinaceus on Learning and Memory in Senescence Accelerated Mice
I-Chen Li, Grape King Bio Ltd., Taiwan
NVND-05 An Adult Case of Noonan Syndrome Associated with Persistent Right Primitive Olfactory Artery and Vertebrobasilar Artery Hypoplasia
Yasushi Shibata, University of Tsukuba, Japan
NVND-06 Neuronal Defects in TAF15-Expressing Flies are Suppressed by Parkin Kiyoung Kim, Soonchunhyang University, South Korea
NVND-07 Predictors of Subclinical Multifocal Atherosclerosis and it’s Relationship with the Metabolic Syndrome
Tatyana Naiden, State North-Western University by I.I. Mechnikova, Russia
NVND-08 Plasma Protein Profiling for Potential Biomarkers in the Early Diagnosis of Alzheimer’s Disease
Yuki Kitamura, Kinjo Gakuin University of Pharmacy, Japan
NVND-09 Emergency Microsurgical Embolectomy in Acute Ischemic Stroke with Diffusion-Negative MRI
Sung Don Kang, Wonkwang University Hospital, South Korea
NVND-10 MicroRNA´s are New Generation Markers of Alzheimer’s Disease David Stejskal, University Hospital Ostrava, Czech Republic
NVND-11 Pharmacological Actions of Hydrogen Sulfide Donors on Sympathetic Neurotransmission in the Bovine Anterior Uvea, In vitro
Catherine A Opere, Creighton University, USA
NVND-12 Frequency of RNF213 p.R4810K Variant in Korean Patients Undergoing Trans-femoral Cerebral Angiography for Stent Insertion
Eunsin Bae, Veterans Health Service Medical Center, South Korea
Poster PresentationsDay-2Program
NVND-2018 MEETING GUIDE 7
•
•
•
•
•
•
•
•
•
•
•
•
NVND-13 The Pyk2/MCU Pathway in the Rat Middle Cerebral Artery Occlusion Model of Ischemic Stroke
Kun Zhang, Hebei Medical University, China
NVND-14 Inhibition of Okadaic acid-induced Tau Hyperphosphorylation by Dendrobium nobile
So-Young Park, Dankook University, South Korea
NVND-15 Functional Characterization of Supt4h using GABAergic Neuron Cells Derived From iPSCs of Huntington’s Disease Patients
Yu-Shiuan Lin, Academia Sinica, Taiwan
NVND-16 Scrapie-associated Polymorphisms of Prion Protein Gene (PRNP) in Korean Native Black Goats
Seonkwan Kim, Chonbuk National University/Korea Zoonosis Research Institute, South Korea
NVND-17 A Double-blind Randomized Control Trial of Vagus Nerve Stimulation for Pediatric Patients with Drug Refractory Epilepsy
Zhao Yang, Tsinghua University, China
Poster PresentationsDay-2Program
8 NVND-2018 MEETING GUIDE
•
•
•
•
•
Session 4 @ Royal Hall 3 Parkinson’s Disease and other Movement Disorders
Chair: Yuko Harada, Yamato Tokushukai Hospital, Japan
09:00 Comparison of Body Composition, Nutritional Habits, and Components in Parkinson´s Disease Patients Living in Urban and Country Side Environmental
Arthur Oscar Schelp, São Paulo State University, Brazil
09:20 Gait Assessment using Non-Motorized Treadmill in Patients with Parkinson Disease and Non-Disabled Individuals
Chia-Yu Kuo, Taipei Veterans General Hospital, Taiwan
09:40 RNA-Sequencing of Parkinson’s Disease Brain Tissues Indicates LRRK2-Mediated Protection by the Long Non-coding RNA NEAT1
Alon Simchovitz, Hebrew University of Jerusalem, Israel
10:00 Increased Expression of AQP4 and AQP9 in Hippocampus of Eclampsia-like Rat Model
Huang Qian, Guangzhou Medical University, China
10:20 Coffee Break @ Foyer Area
12:00 Lunch & Departures @ Crown Room
WEDNESDAY, OCTOBER 17, 2018Day-3Program
NVND-2018 MEETING GUIDE 9
Notes ______________________________________________
__________________________________________________
__________________________________________________
__________________________________________________
__________________________________________________
__________________________________________________
__________________________________________________
__________________________________________________
__________________________________________________
__________________________________________________
__________________________________________________
__________________________________________________
__________________________________________________
__________________________________________________
__________________________________________________
__________________________________________________
__________________________________________________
__________________________________________________
__________________________________________________
__________________________________________________
__________________________________________________
__________________________________________________
__________________________________________________
__________________________________________________
Notes ______________________________________________
__________________________________________________
__________________________________________________
__________________________________________________
__________________________________________________
__________________________________________________
__________________________________________________
__________________________________________________
__________________________________________________
__________________________________________________
__________________________________________________
__________________________________________________
__________________________________________________
__________________________________________________
__________________________________________________
__________________________________________________
__________________________________________________
__________________________________________________
__________________________________________________
__________________________________________________
__________________________________________________
__________________________________________________
__________________________________________________
__________________________________________________
A non-profit organization (501 C 3 status pending)
# 8105, Rasor Blvd - Suite #112, PLANO, TX 75024, USA
Ph: +1-408-426-4832, +1-408-426-4833Toll Free: +1-844-395-4102; Fax: +1-408-426-4869
Email: [email protected]; [email protected]: www.unitedscientificgroup.com/conferences/neurovascular-and-neurodegenerative-diseases
UNITED Scientific Group
We wish to see you
@ NVND-2019
